{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:47:20Z","timestamp":1774896440191,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.anplas.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T01:01:30Z","timestamp":1493341290000},"page":"274-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Non-surgical treatments for hidradenitis suppurativa: A systematic review"],"prefix":"10.1016","volume":"62","author":[{"given":"E.","family":"Robert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-P.","family":"Konstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Grolleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Laloze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chaput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anplas.2017.03.012_bib0005","series-title":"Hidradenitis suppurativa","author":"Jemec","year":"2006"},{"key":"10.1016\/j.anplas.2017.03.012_bib0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol."},{"issue":"3 Suppl.","key":"10.1016\/j.anplas.2017.03.012_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12788\/j.sder.0091","article-title":"Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology","volume":"33","author":"Micheletti","year":"2014","journal-title":"Semin Cutan Med Surg"},{"issue":"5 Suppl. 1","key":"10.1016\/j.anplas.2017.03.012_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaad.2015.07.045","article-title":"Pathophysiology of hidradenitis suppurativa: an update","volume":"73","author":"Prens","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","article-title":"Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands","volume":"122","author":"Yu","year":"1990","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.anplas.2017.03.012_bib0030","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.12550","article-title":"Hidradenitis suppurativa: the role of immune dysregulation","volume":"53","author":"Kelly","year":"2014","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.anplas.2017.03.012_bib0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","article-title":"Considering hidradenitis suppurativa as a bacterial biofilm disease","volume":"65","author":"Kathju","year":"2012","journal-title":"FEMS Immunol Med Microbiol."},{"issue":"5 Suppl. 1","key":"10.1016\/j.anplas.2017.03.012_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.anplas.2017.03.012_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000269836","article-title":"Clinicopathological study of 13\u00a0cases of squamous cell carcinoma complicating hidradenitis suppurativa","volume":"220","author":"Lavogiez","year":"2010","journal-title":"Dermatology."},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0974-7796.152945","article-title":"Scroto-perineal hidradenitis suppurativa complicated by giant scrotal elephantiasis","volume":"7","author":"Alharbi","year":"2015","journal-title":"Urol Ann"},{"key":"10.1016\/j.anplas.2017.03.012_bib0060","series-title":"Current therapy","first-page":"592","article-title":"Hidradenitis suppurativa","author":"Mullins","year":"1972"},{"key":"10.1016\/j.anplas.2017.03.012_bib0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106\u00a0patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.anplas.2017.03.012_bib0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.anplas.2017.03.012_bib0075","unstructured":"OCEBM levels of evidence working group. \u201cThe Oxford 2011 levels of evidence\u201d. Oxford centre for evidence-based medicine. http:\/\/www.cebm.net\/index.aspx?o=5653."},{"key":"10.1016\/j.anplas.2017.03.012_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12222","article-title":"Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118\u00a0patients","author":"Sand","year":"2015","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.anplas.2017.03.012_bib0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/09546634.2012.683767","article-title":"Long-term efficacy of infliximab in hidradenitis suppurativa","volume":"23","author":"Paradela","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjd.12713","article-title":"Four-weekly infliximab in the treatment of severe hidradenitis suppurativa","volume":"170","author":"Moriarty","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7\u00a0consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl.","key":"10.1016\/j.anplas.2017.03.012_bib0125","first-page":"s15","article-title":"A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa","volume":"11","author":"Sotiriou","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"12","key":"10.1016\/j.anplas.2017.03.012_bib0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2010.04638.x","article-title":"Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy","volume":"49","author":"Arenbergerova","year":"2010","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ajd.12136","article-title":"Moderate to severe hidradenitis suppurativa treated with biological therapies","volume":"55","author":"Chinniah","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555-0545","article-title":"Etanercept for the treatment of hidradenitis suppurativa","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm Venereol."},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase\u00a0II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0150","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.anplas.2017.03.012_bib0160","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2007.07.032","article-title":"Efalizumab for the treatment of refractory hidradenitis suppurativa","volume":"57","author":"Strober","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jdv.12438","article-title":"Use of biological treatments in patients with hidradenitis suppurativa","volume":"29","author":"Martin-Ezquerra","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.anplas.2017.03.012_bib0170","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/bjd.13186","article-title":"Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience","volume":"171","author":"Zhang","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjd.14199","article-title":"Antitumour necrosis factor-(therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013","volume":"174","author":"Sbidian","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0180","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1684\/ejd.2012.1795","article-title":"Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa","volume":"22","author":"Lesage","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.anplas.2017.03.012_bib0185","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anplas.2017.03.012_bib0190","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.03.037","article-title":"Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis","author":"Shelton","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anplas.2017.03.012_bib0195","unstructured":"European medicines agency. First medicine recommended for approval for hidradenitis suppurativa. Press Office. 25 June 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2015\/06\/WC500188809.pdf."},{"key":"10.1016\/j.anplas.2017.03.012_bib0200","unstructured":"Department of health and human services. Food and Drug Administration Silver Spring MD 20993. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2015\/125057Orig1s393ltr.pdf."},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0210","series-title":"Hidradenitis suppurativa","first-page":"86","article-title":"Bacteriology of Hidradenitis Suppurativa","author":"Oprica","year":"2006"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"Van der Zee","year":"2009","journal-title":"Dermatology."},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116\u00a0consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology."},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0225","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23\u00a0patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J Dermatolog Treat."},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0245","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24\u00a0patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology."},{"issue":"6","key":"10.1016\/j.anplas.2017.03.012_bib0250","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ad.2013.10.016","article-title":"Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5\u00a0cases","volume":"105","author":"Andino Navarrete","year":"2014","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/c2pp25124h","article-title":"A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20\u00a0Italian dermatology departments. Part\u00a01: inflammatory and aesthetic indications","volume":"12","author":"Calzavara-Pinton","year":"2013","journal-title":"Photochem Photobiol Sci"},{"issue":"7","key":"10.1016\/j.anplas.2017.03.012_bib0260","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1111\/j.1365-2230.2008.03094.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases","volume":"34","author":"Sotiriou","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0265","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2133.2005.06475.x","article-title":"Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa","volume":"152","author":"Strauss","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0270","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjd.13385","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach","volume":"172","author":"Valladares-Narganes","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ced.12459","article-title":"New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study","volume":"40","author":"Fadel","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.10193.x","article-title":"Bath psoralen plus ultraviolet\u00a0A for hidradenitis suppurativa: a review of 13\u00a0patients","volume":"164","author":"Shareef","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0285","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","article-title":"Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study","volume":"128","author":"Highton","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09546630902882063","article-title":"Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases","volume":"20","author":"Passeron","year":"2009","journal-title":"J Dermatolog Treat."},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0295","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0300","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17\u00a0patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archderm.1989.01670140098019","article-title":"Etretinate. Persistent serum levels after long-term therapy","volume":"125","author":"DiGiovanna","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0315","series-title":"Point d\u2019information","author":"ANSM","year":"2014"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0320","first-page":"155","article-title":"Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age","volume":"150","author":"Verdolini","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","article-title":"Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and estrogen therapy","volume":"115","author":"Sawers","year":"1986","journal-title":"Br J Dermatol"},{"issue":"6665","key":"10.1016\/j.anplas.2017.03.012_bib0330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.298.6665.28","article-title":"Hidradenitis suppurativa associated with use of oral contraceptives","volume":"298","author":"Stellon","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.anplas.2017.03.012_bib0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64\u00a0female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09546630510031403","article-title":"Hidradenitis suppurativa treated with finasteride","volume":"16","author":"Joseph","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0350","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20\u00a0women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.anplas.2017.03.012_bib0355","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2133.1996.d01-1069.x","article-title":"Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions","volume":"135","author":"Boer","year":"1996","journal-title":"Br J Dermatol."},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09546634.2015.1088128","article-title":"Cyclosporine treatment of severe Hidradenitis suppurativa \u2013 A case series","volume":"27","author":"Anderson","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0365","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"Van der Zee","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0375","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.anplas.2017.03.012_bib0380","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0385","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.13346","article-title":"Fumarates, a new treatment option for therapy-resistant hidradenitis suppurativa: a prospective open-label pilot study","volume":"172","author":"Deckers","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0390","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2133.2007.08069.x","article-title":"Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63\u00a0cases","volume":"157","author":"Goo","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0395","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen","year":"2015","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0400","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen","year":"2010","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.anplas.2017.03.012_bib0405","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0410","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/0974-2077.101377","article-title":"Use of lasers for the management of refractory cases of hidradenitis suppurativa and pilonidal sinus","volume":"5","author":"Jain","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.anplas.2017.03.012_bib0420","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2013.2213","article-title":"Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampicin-clindamycin combination","volume":"24","author":"Join-Lambert","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0430","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0435","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09546634.2011.571657","article-title":"Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa","volume":"23","author":"Van Rappard","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.anplas.2017.03.012_bib0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-1025","article-title":"Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers","volume":"91","author":"Delage","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.anplas.2017.03.012_bib0445","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.anplas.2017.03.012_bib0450","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase\u00a0II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.anplas.2017.03.012_bib0455","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archdermatol.2009.49","article-title":"Long-term successful adalimumab therapy in severe hidradenitis suppurativa","volume":"145","author":"Blanco","year":"2009","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.anplas.2017.03.012_bib0460","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2133.2008.08735.x","article-title":"Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?","volume":"159","author":"Brunasso","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anplas.2017.03.012_bib0465","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000102032","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"215","author":"Fern\u00e1ndez-Vozmediano","year":"2007","journal-title":"Dermatology."},{"issue":"4","key":"10.1016\/j.anplas.2017.03.012_bib0470","first-page":"381","article-title":"Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results","volume":"10","author":"Schweiger","year":"2011","journal-title":"J Drugs Dermatol"}],"container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126017300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126017300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:33:27Z","timestamp":1759530807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0294126017300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0294126017300511"],"URL":"https:\/\/doi.org\/10.1016\/j.anplas.2017.03.012","relation":{},"ISSN":["0294-1260"],"issn-type":[{"value":"0294-1260","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-surgical treatments for hidradenitis suppurativa: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Annales de Chirurgie Plastique Esth\u00e9tique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anplas.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}